DMAC — DiaMedica Therapeutics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates DMAC Bullish with a Setup Score of 58, net conviction 29, actionability 117. How the Setup Score works →

Total Setup Score58
Directional BiasBullish
Net Conviction29
Actionability117 (in range)

Key signals behind this score

About DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$6.52
Market Cap$352M
Float25.3M
Shares Outstanding53.9M
Price/Sales (TTM)66.68
vs. Analyst Target+137.7% to analyst PT
Dividend RateNone
Analyst Target Price$15.50 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$12.3M -$21,000 -$12.7M
2021 N/A -$13.6M -$24,000 -$13.5M
2022 N/A -$13.7M -$25,000 -$13.6M
2023 N/A -$19.4M -$30,000 -$19.3M
2024 N/A -$24.4M -$39,000 -$24.4M
2025 N/A -$32.8M N/A -$32.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 N/A -$8.6M
Dec 2025 -$27,999 -$8.7M
Mar 2026 N/A -$10.0M
Jun 2026 N/A -$10.1M

Ownership & Float

Insider Ownership27.8%
Institutional Ownership40.9%
Short Float20.6%
% of All Funds Holding1.01%
Number of Funds Holding89

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$6.87Near-term / short-term trend
Weekly40-Week SMA$7.18Medium-term trend
Weekly80-Week SMA$6.18Cyclical trend (business cycle)
Weekly200-Week SMA$4.30Secular trend (multi-year)
Monthly10-Month SMA$7.13Near-term monthly trend
Monthly20-Month SMA$6.17Medium-term monthly trend
Monthly40-Month SMA$4.77Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$5.80 support 2.49x 10 months ago
$4.20 support 1.86x 11 months ago
$3.00 support 1.39x 24 months ago

Historical Earnings Reactions (51 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.06% 0.00% 33.33% 27.27% -12.93%
1 Day -0.86% 0.00% 35.29% 27.27% -34.68%
1 Week 1.90% 0.00% 49.02% 62.55% -31.46%
2 Weeks 2.16% 0.12% 50.00% 62.55% -37.40%
1 Month 1.26% -1.81% 46.00% 76.06% -44.44%

Next earnings: October 29, 2026 (65 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-1.5%50.0%14
Feb10.4%71.4%14
Mar0.5%35.7%14
Apr3.3%50.0%14
May4.3%50.0%14
Jun14.3%57.1%14
Jul-8.4%28.6%14
Aug0.7%46.2%13
Sep1.3%50.0%14
Oct-4.1%35.7%14
Nov-6.6%42.9%14
Dec7.1%35.7%14

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.13% 32.1% 663
Tuesday 0.18% 32.2% 726
Wednesday 0.15% 34.4% 724
Thursday 0.29% 33.1% 710
Friday -0.07% 33.1% 708

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 40.9%

Insider Transactions — Smart Summary

Total insider ownership: 27.8%

12-Month Insider Activity Summary

Total Filings2
Net Value+N/A
Net Shares Change2,061,277
% of Float8.1%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
STAHLBERG JAN +$13.6M 2 2 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-12-08 STAHLBERG JAN +$7.6M Transaction at $7.19, now -9.3%
2025-09-04 STAHLBERG JAN +$6.0M Transaction at $5.96, now +9.4%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for DiaMedica Therapeutics Inc (DMAC) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for DMAC on Trend Edge →